Profile data is unavailable for this security.
About the company
RIBOMIC Inc. is engaged in the drug discovery business based on the platform Ribomic Aptamer Refined Therapeutics System related to aptamer drug discovery technology. Its drug discovery business is divided into self discovery and co-discovery divisions. Self Drug Discovery division develops aptamer and licenses and out the results to pharmaceutical companies. The Co-Discovery division earns the research expenses paid by the alliance partner for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.
- Revenue in JPY (TTM)2.11m
- Net income in JPY-949.28m
- Incorporated2003
- Employees24.00
- LocationRibomic Inc6F, Shirokanedai Usui Bldg.3-16-13, ShirokanedaiMINATO-KU 108-0071JapanJPN
- Phone+81 334403303
- Fax+81 334403729
- Websitehttps://www.ribomic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PhoenixBio Co Ltd | 1.62bn | -126.00m | 1.45bn | 70.00 | -- | 0.8605 | -- | 0.8956 | -31.31 | -31.31 | 408.76 | 416.03 | 0.5679 | 1.05 | 5.81 | 23,168,070.00 | -4.41 | -4.04 | -6.32 | -5.28 | 72.27 | 65.88 | -7.77 | -6.97 | 3.65 | -1.07 | 0.207 | -- | -19.24 | 6.91 | -94.65 | -- | -9.96 | -- |
| Ribomic Inc | 2.11m | -949.28m | 3.38bn | 24.00 | -- | 1.03 | -- | 1,603.44 | -25.76 | -25.76 | 0.057 | 80.86 | 0.0006 | -- | 0.0677 | 87,791.66 | -25.76 | -30.52 | -26.68 | -31.71 | -- | -- | -45,053.58 | -1,777.84 | 30.87 | -- | 0.00 | -- | -100.00 | -- | 38.04 | -- | 4.42 | -- |
| Human Metabolome Technologies Inc | 1.38bn | 246.02m | 3.58bn | 58.00 | 14.52 | 1.97 | 10.24 | 2.58 | 41.59 | 41.59 | 234.08 | 306.43 | 0.6291 | 8.87 | 7.76 | 23,872,380.00 | 11.18 | 8.49 | 14.00 | 10.80 | 65.13 | 69.25 | 17.77 | 13.21 | 3.73 | 33.22 | 0.1088 | 18.31 | 3.57 | -- | -14.88 | -- | -- | -- |
| Cyfuse Biomedical KK | 57.69m | -718.81m | 3.94bn | 21.00 | -- | 1.44 | -- | 68.23 | -89.81 | -89.81 | 7.24 | 335.21 | 0.0147 | 0.5261 | 40.19 | 2,747,238.00 | -18.36 | -- | -21.62 | -- | 55.40 | -- | -1,245.95 | -- | 5.52 | -91.45 | 0.2268 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| D.Western Therapeutics Institute Inc | 464.18m | -1.09bn | 3.95bn | 21.00 | -- | 4.03 | -- | 8.51 | -33.74 | -33.74 | 14.43 | 25.80 | 0.19 | 0.3314 | 4.10 | 22,103,620.00 | -44.77 | -13.06 | -47.81 | -14.36 | 91.27 | 94.29 | -235.62 | -72.51 | 18.24 | -- | 0.5644 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| BrightPath Biotherapeutics Co Ltd | 84.00k | -1.15bn | 4.61bn | 24.00 | -- | 3.67 | -- | 54,830.12 | -16.73 | -16.73 | 0.0012 | 14.73 | 0.00006 | -- | 2.80 | 3,500.00 | -80.63 | -51.56 | -97.29 | -54.32 | 75.00 | 68.63 | -1,372,495.00 | -22,321.82 | -- | -- | 0.2085 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
| FunPep Co Ltd | 530.00k | -727.29m | 4.70bn | 15.00 | -- | 1.76 | -- | 8,866.56 | -29.40 | -29.40 | 0.0215 | 82.55 | 0.0002 | -- | -- | 35,333.33 | -26.27 | -27.10 | -29.12 | -28.75 | -- | -- | -137,223.40 | -815.82 | 5.06 | -1,004.01 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| DNA Chip Research Inc | 766.32m | -118.13m | 4.75bn | 37.00 | -- | 6.77 | -- | 6.20 | -18.29 | -18.29 | 116.80 | 103.64 | 0.9159 | 8.50 | 7.86 | 20,711,350.00 | -14.12 | -23.49 | -17.74 | -26.70 | 38.52 | 14.28 | -15.41 | -54.10 | 2.78 | -641.51 | 0.00 | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
| Kidswell Bio Corp | 3.60bn | -883.62m | 4.80bn | 42.00 | -- | 5.60 | -- | 1.33 | -22.78 | -22.78 | 92.26 | 21.08 | 0.9182 | 2.73 | 6.63 | 85,697,070.00 | -22.54 | -57.41 | -35.96 | -81.13 | 36.17 | 55.20 | -24.55 | -123.52 | 1.64 | -17.95 | 0.7132 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| Kringle Pharma Inc | 80.04m | -756.45m | 5.86bn | 13.00 | -- | 2.78 | -- | 73.18 | -118.21 | -118.21 | 12.71 | 309.55 | 0.0298 | -- | 1.15 | -- | -28.14 | -19.17 | -30.03 | -20.40 | -- | -- | -945.12 | -181.86 | 19.20 | -- | -- | -- | 15.58 | -- | 11.44 | -- | -- | -- |
| Veritas In Silico Inc | 246.24m | -148.31m | 5.87bn | 15.00 | -- | 2.55 | -- | 23.84 | -23.92 | -23.92 | 38.93 | 354.61 | 0.1227 | -- | -- | 16,415,930.00 | -7.39 | -- | -7.65 | -- | -- | -- | -60.23 | -- | 67.03 | -- | -- | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Carna Biosciences, Inc. | 1.40bn | -1.51bn | 5.94bn | 67.00 | -- | 2.11 | -- | 4.24 | -85.98 | -85.98 | 80.34 | 147.09 | 0.391 | 1.19 | 13.59 | 20,922,580.00 | -42.15 | -14.45 | -45.45 | -16.95 | 87.53 | 90.59 | -107.80 | -35.42 | 11.11 | -- | 0.0215 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
Data as of Nov 22 2024. Currency figures normalised to Ribomic Inc's reporting currency: Japanese Yen JPY
